AbbVie Market Cap 2010-2019 | ABBV

AbbVie market cap history and chart from 2010 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. AbbVie market cap as of March 27, 2020 is $109.02B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $109.023B $33.266B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $333.683B 14.58
Roche Holding AG (RHHBY) Switzerland $265.584B 0.00
Merck (MRK) United States $186.492B 14.17
Novartis AG (NVS) Switzerland $182.748B 15.22
Pfizer (PFE) United States $176.138B 10.76
Novo Nordisk (NVO) Denmark $134.408B 23.07
Eli Lilly (LLY) United States $128.578B 22.24
Bristol-Myers Squibb (BMY) United States $117.955B 11.19
AstraZeneca (AZN) United Kingdom $111.168B 23.93
Sanofi (SNY) France $107.553B 12.78
GlaxoSmithKline (GSK) United Kingdom $92.949B 11.79
Bayer (BAYRY) Germany $53.155B 7.66
H Lundbeck (HLUYY) Denmark $5.819B 10.11